Alveo Technologies Partners with CDC to Advance Rapid Avian Flu Diagnostics
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Emerging & Zoonotic Diseases, Molecular Diagnostics |
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
Read MorePosted by Chris Wolski | Nov 13, 2024 | Diagnostic Technologies |
For the second year in a row, industry experts predict automation and AI as top clinical laboratory trends in 2025.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Sequencing Systems |
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Dementias & Alzheimer’s, Molecular Diagnostics |
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Gastrointestinal Infections |
Castle Biosciences’ Barrett’s Esophagus test delivered over 25,000 reports to support risk assessment for Barrett’s Esophagus patients.
Read More